Literature DB >> 31646285

Type 2 diabetes and susceptibility to atrial fibrillation: the two facets of downregulation of MiR-126?

Raffaella Mormile1.   

Abstract

Entities:  

Year:  2018        PMID： 31646285      PMCID： PMC6739896          DOI： 10.1097/XCE.0000000000000156

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN： 2574-0954


× No keyword cloud information.
  10 in total

Review 1.  Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice.

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  Arch Cardiovasc Dis       Date:  2015-04-06       Impact factor: 2.340

2.  MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1.

Authors:  Song-Tao Tang; Feng Wang; Min Shao; Yuan Wang; Hua-Qing Zhu
Journal:  Vascul Pharmacol       Date:  2016-12-18       Impact factor: 5.773

3.  Protective Effects of MicroRNA-126 on Human Cardiac Microvascular Endothelial Cells Against Hypoxia/Reoxygenation-Induced Injury and Inflammatory Response by Activating PI3K/Akt/eNOS Signaling Pathway.

Authors:  Hong-Hui Yang; Yan Chen; Chuan-Yu Gao; Zhen-Tian Cui; Jian-Min Yao
Journal:  Cell Physiol Biochem       Date:  2017-06-05

4.  The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway.

Authors:  Keng Wu; Yi Yang; Yun Zhong; Hala Mustafa Ammar; Peihua Zhang; Runmin Guo; Hua Liu; Chuanfang Cheng; Thomas M Koroscil; Yanfang Chen; Shiming Liu; Ji C Bihl
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-08       Impact factor: 4.310

5.  Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo.

Authors:  Jichun Wang; Hongxin Yang; Xiaorong Hu; Wenwen Fu; Jing Xie; Xiaoya Zhou; Weipan Xu; Hong Jiang
Journal:  J Surg Res       Date:  2013-03-17       Impact factor: 2.192

6.  Hyperglycemia and Advanced Glycation End Products Regulate miR-126 Expression in Endothelial Progenitor Cells.

Authors:  Yeting Li; Qing Zhou; ChongZhe Pei; Bo Liu; MaoQuan Li; Lu Fang; YingGang Sun; YiGang Li; Shu Meng
Journal:  J Vasc Res       Date:  2016-09-28       Impact factor: 1.934

7.  Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.

Authors:  Lynette Pretorius; Xiao-Jun Du; Elizabeth A Woodcock; Helen Kiriazis; Ruby C Y Lin; Silvana Marasco; Robert L Medcalf; Ziqiu Ming; Geoffrey A Head; Joon Win Tan; Nelly Cemerlang; Junichi Sadoshima; Tetsuo Shioi; Seigo Izumo; Elena V Lukoshkova; Anthony M Dart; Garry L Jennings; Julie R McMullen
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

8.  Increased serum HMGB1 is related to oxidative stress in patients with atrial fibrillation.

Authors:  Yongbo Wu; Kai Zhang; Lin Zhao; Jie Guo; Xiaorong Hu; Zhiqiang Chen
Journal:  J Int Med Res       Date:  2013-12       Impact factor: 1.671

9.  Biological significance of miR-126 expression in atrial fibrillation and heart failure.

Authors:  X J Wei; M Han; F Y Yang; G C Wei; Z G Liang; H Yao; C W Ji; R S Xie; C L Gong; Y Tian
Journal:  Braz J Med Biol Res       Date:  2015-08-25       Impact factor: 2.590

10.  MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.

Authors:  Fabiola Olivieri; Liana Spazzafumo; Massimiliano Bonafè; Rina Recchioni; Francesco Prattichizzo; Fiorella Marcheselli; Luigina Micolucci; Emanuela Mensà; Angelica Giuliani; Gabriele Santini; Mirko Gobbi; Raffaella Lazzarini; Massimo Boemi; Roberto Testa; Roberto Antonicelli; Antonio Domenico Procopio; Anna Rita Bonfigli
Journal:  Oncotarget       Date:  2015-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.